It's time for ES to ditch his sock-puppets DP and CJ and nominate credible replacements.
SK should make a convincing case for PS-targeting investments and be clearly reiterate that the clinical trials will be outsourced with ongoing expenditures <<$30*10^6 in order to counter Ronin and/or make them release a more detailed statement concerning their plans for the IP. Otherwise, a Ronin takeover appears to be a no brainer.
In my opinion at the moment... Things can change and I hope they will for the better.